Greater understanding of the molecular mechanisms at play in oncogenesis, such as the mammalian target of rapamycin (mTOR) pathway, has shown that the interplay between DM and cancer is much more complex than originally thought [33]. The gene discussed is MTOR; the disease is diabetes mellitus.